

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.54582680 |
| 2 | skeletal muscle contraction (GO:0003009) | 5.07876977 |
| 3 | muscle filament sliding (GO:0030049) | 4.90330035 |
| 4 | actin-myosin filament sliding (GO:0033275) | 4.90330035 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 4.81216152 |
| 6 | actin-mediated cell contraction (GO:0070252) | 3.80826982 |
| 7 | creatine metabolic process (GO:0006600) | 3.71520634 |
| 8 | striated muscle contraction (GO:0006941) | 3.43298954 |
| 9 | myofibril assembly (GO:0030239) | 3.35266270 |
| 10 | response to muscle activity (GO:0014850) | 3.26799540 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23600930 |
| 12 | mannose metabolic process (GO:0006013) | 3.20705148 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.13714551 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.13047260 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13047260 |
| 16 | skeletal muscle adaptation (GO:0043501) | 3.09145114 |
| 17 | actin filament-based movement (GO:0030048) | 3.07912677 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 3.06164303 |
| 19 | response to inactivity (GO:0014854) | 2.97548029 |
| 20 | skeletal muscle fiber development (GO:0048741) | 2.94223001 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79281973 |
| 22 | germinal center formation (GO:0002467) | 2.74270515 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 2.68965660 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66817888 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 2.66051797 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.64741165 |
| 27 | glycogen catabolic process (GO:0005980) | 2.58685920 |
| 28 | myotube cell development (GO:0014904) | 2.55390947 |
| 29 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54600531 |
| 30 | neuronal action potential propagation (GO:0019227) | 2.53323771 |
| 31 | muscle contraction (GO:0006936) | 2.52543661 |
| 32 | cardiac muscle contraction (GO:0060048) | 2.51158828 |
| 33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.50283971 |
| 34 | macroautophagy (GO:0016236) | 2.50006220 |
| 35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.49582699 |
| 36 | glucan catabolic process (GO:0009251) | 2.47113524 |
| 37 | response to peptidoglycan (GO:0032494) | 2.41473473 |
| 38 | plasma membrane repair (GO:0001778) | 2.38224485 |
| 39 | cellular polysaccharide catabolic process (GO:0044247) | 2.38032900 |
| 40 | muscle system process (GO:0003012) | 2.37335327 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 2.33854506 |
| 42 | synaptic transmission, cholinergic (GO:0007271) | 2.31381816 |
| 43 | muscle adaptation (GO:0043500) | 2.28590108 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.25541261 |
| 45 | striated muscle adaptation (GO:0014888) | 2.25513755 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.24161647 |
| 47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.23944775 |
| 48 | striated muscle atrophy (GO:0014891) | 2.23178549 |
| 49 | fructose metabolic process (GO:0006000) | 2.22585640 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 2.21987752 |
| 51 | response to muramyl dipeptide (GO:0032495) | 2.20941418 |
| 52 | sarcomere organization (GO:0045214) | 2.19380975 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.18611179 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.18611179 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 2.18611179 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 2.18611179 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 2.18611179 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.18611179 |
| 59 | response to activity (GO:0014823) | 2.17550055 |
| 60 | polysaccharide catabolic process (GO:0000272) | 2.17247275 |
| 61 | neuromuscular synaptic transmission (GO:0007274) | 2.16132865 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.13707969 |
| 63 | positive regulation of heat generation (GO:0031652) | 2.13291378 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 2.11501487 |
| 65 | cellular response to nicotine (GO:0071316) | 2.10360669 |
| 66 | amino sugar catabolic process (GO:0046348) | 2.08730950 |
| 67 | muscle fiber development (GO:0048747) | 2.08367954 |
| 68 | muscle cell cellular homeostasis (GO:0046716) | 2.07718149 |
| 69 | lysosome organization (GO:0007040) | 2.06409596 |
| 70 | lytic vacuole organization (GO:0080171) | 2.06409596 |
| 71 | T-helper 1 type immune response (GO:0042088) | 2.06164981 |
| 72 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.05042273 |
| 73 | cardiac myofibril assembly (GO:0055003) | 2.04860740 |
| 74 | regulation of ARF GTPase activity (GO:0032312) | 2.04859278 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.04647427 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.04623706 |
| 77 | virion attachment to host cell (GO:0019062) | 2.04214156 |
| 78 | adhesion of symbiont to host cell (GO:0044650) | 2.04214156 |
| 79 | negative regulation of granulocyte differentiation (GO:0030853) | 2.01965423 |
| 80 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.01938848 |
| 81 | muscle hypertrophy (GO:0014896) | 2.01760214 |
| 82 | skeletal muscle tissue development (GO:0007519) | 2.01407101 |
| 83 | positive regulation of myotube differentiation (GO:0010831) | 2.00809702 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 2.00731803 |
| 85 | macrophage activation (GO:0042116) | 1.99447792 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 1.99002050 |
| 87 | interferon-gamma production (GO:0032609) | 1.98423224 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 1.97818244 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 1.97730995 |
| 90 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 1.96189425 |
| 91 | N-acetylneuraminate metabolic process (GO:0006054) | 1.96137963 |
| 92 | regulation of cholesterol storage (GO:0010885) | 1.95962541 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 1.95210924 |
| 94 | nitric oxide mediated signal transduction (GO:0007263) | 1.93913592 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 1.91918412 |
| 96 | cardiac muscle hypertrophy (GO:0003300) | 1.89951831 |
| 97 | neutrophil activation involved in immune response (GO:0002283) | 1.89923126 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 1.89578362 |
| 99 | regulation of necroptotic process (GO:0060544) | 1.89063439 |
| 100 | muscle organ development (GO:0007517) | 1.87910910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.79941824 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.38959838 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94248825 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38666238 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35064110 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.14577780 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00128902 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.99919787 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95282240 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79262365 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75095040 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72251803 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69671293 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66639120 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63500967 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62935407 |
| 17 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.59871973 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58009437 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56977276 |
| 20 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52804314 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51495005 |
| 22 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48843890 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47383246 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47054999 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46487811 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40613096 |
| 27 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40413601 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39227407 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38651421 |
| 30 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37573153 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36821467 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36391935 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36140687 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36048341 |
| 35 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35485056 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35043645 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34841774 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34608583 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32842141 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31626449 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.31217333 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30253476 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30014353 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27262405 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22520616 |
| 46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22518738 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19422477 |
| 48 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19184262 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19044100 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18491475 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17958206 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17132207 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16979416 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16426367 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14525976 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14159360 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13561566 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13075860 |
| 59 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12692148 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11558799 |
| 61 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11195007 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10769979 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10126594 |
| 64 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09693151 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07677828 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06852179 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.06548732 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.06463650 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05541154 |
| 70 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05502579 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05380290 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04157228 |
| 73 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04014069 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02815829 |
| 75 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00589042 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99416302 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98991418 |
| 78 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97675438 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97540992 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96524906 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95063655 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94206232 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93626990 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93430993 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93221133 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92474687 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92367048 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91207163 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91136207 |
| 90 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89574118 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89058766 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88741655 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87719552 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87464188 |
| 95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87392592 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86038460 |
| 97 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85839403 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85598238 |
| 99 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85580126 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85521881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.02700702 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 3.96183885 |
| 3 | MP0000751_myopathy | 3.07468412 |
| 4 | MP0000749_muscle_degeneration | 2.99826602 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.73295320 |
| 6 | MP0005451_abnormal_body_composition | 2.65376265 |
| 7 | MP0004510_myositis | 2.53594406 |
| 8 | MP0003303_peritoneal_inflammation | 2.40531131 |
| 9 | MP0009840_abnormal_foam_cell | 2.33719666 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.27868185 |
| 11 | MP0004130_abnormal_muscle_cell | 2.18975221 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.17979094 |
| 13 | MP0002106_abnormal_muscle_physiology | 2.05244011 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.00880397 |
| 15 | MP0000747_muscle_weakness | 2.00789101 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.98809116 |
| 17 | MP0003724_increased_susceptibility_to | 1.96229982 |
| 18 | MP0003436_decreased_susceptibility_to | 1.93980026 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.93651096 |
| 20 | MP0000759_abnormal_skeletal_muscle | 1.87291185 |
| 21 | MP0004270_analgesia | 1.74780438 |
| 22 | MP0005369_muscle_phenotype | 1.68266453 |
| 23 | MP0005387_immune_system_phenotype | 1.65778705 |
| 24 | MP0001790_abnormal_immune_system | 1.65778705 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.65553731 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.53019261 |
| 27 | MP0005620_abnormal_muscle_contractility | 1.52777355 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.52381530 |
| 29 | MP0005671_abnormal_response_to | 1.51345497 |
| 30 | MP0002419_abnormal_innate_immunity | 1.49904243 |
| 31 | MP0006082_CNS_inflammation | 1.49575684 |
| 32 | MP0003879_abnormal_hair_cell | 1.48098720 |
| 33 | MP0003690_abnormal_glial_cell | 1.45764035 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.45057960 |
| 35 | MP0009278_abnormal_bone_marrow | 1.44351353 |
| 36 | MP0002822_catalepsy | 1.41414376 |
| 37 | MP0005025_abnormal_response_to | 1.38531860 |
| 38 | MP0002269_muscular_atrophy | 1.36670576 |
| 39 | MP0003075_altered_response_to | 1.36169490 |
| 40 | MP0000685_abnormal_immune_system | 1.31379906 |
| 41 | MP0001835_abnormal_antigen_presentation | 1.24640941 |
| 42 | MP0002971_abnormal_brown_adipose | 1.23944874 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.23864497 |
| 44 | MP0001800_abnormal_humoral_immune | 1.23710545 |
| 45 | MP0009785_altered_susceptibility_to | 1.23583352 |
| 46 | MP0000343_altered_response_to | 1.21313056 |
| 47 | MP0000604_amyloidosis | 1.19188982 |
| 48 | MP0002723_abnormal_immune_serum | 1.17898599 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.14560007 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.14165496 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.12022271 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.11691026 |
| 53 | MP0009764_decreased_sensitivity_to | 1.10796866 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.10616001 |
| 55 | MP0004859_abnormal_synaptic_plasticity | 1.10159446 |
| 56 | MP0005330_cardiomyopathy | 1.09937555 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.06629664 |
| 58 | MP0005535_abnormal_body_temperature | 1.06003648 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.04058542 |
| 60 | MP0008004_abnormal_stomach_pH | 1.03744534 |
| 61 | MP0005166_decreased_susceptibility_to | 1.03178350 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.02028170 |
| 63 | MP0002972_abnormal_cardiac_muscle | 1.01321879 |
| 64 | MP0004084_abnormal_cardiac_muscle | 1.00883226 |
| 65 | MP0001501_abnormal_sleep_pattern | 1.00700553 |
| 66 | MP0001819_abnormal_immune_cell | 1.00540906 |
| 67 | MP0005266_abnormal_metabolism | 0.99681160 |
| 68 | MP0003329_amyloid_beta_deposits | 0.98553482 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 0.95839307 |
| 70 | MP0002638_abnormal_pupillary_reflex | 0.95694753 |
| 71 | MP0005310_abnormal_salivary_gland | 0.93875899 |
| 72 | MP0002254_reproductive_system_inflammat | 0.89968728 |
| 73 | MP0004043_abnormal_pH_regulation | 0.89600798 |
| 74 | MP0008874_decreased_physiological_sensi | 0.88032694 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.87792440 |
| 76 | MP0002933_joint_inflammation | 0.87455860 |
| 77 | MP0003045_fibrosis | 0.87236508 |
| 78 | MP0000733_abnormal_muscle_development | 0.87216568 |
| 79 | MP0008469_abnormal_protein_level | 0.86798743 |
| 80 | MP0002108_abnormal_muscle_morphology | 0.86699602 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.86479285 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.86451777 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.86405559 |
| 84 | MP0004233_abnormal_muscle_weight | 0.84986880 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.84115018 |
| 86 | MP0002064_seizures | 0.83623956 |
| 87 | MP0003279_aneurysm | 0.80074591 |
| 88 | MP0003633_abnormal_nervous_system | 0.79105164 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.78205457 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 0.77530051 |
| 91 | MP0003635_abnormal_synaptic_transmissio | 0.76521062 |
| 92 | MP0005448_abnormal_energy_balance | 0.75864793 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.75409120 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.75234982 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.75234982 |
| 96 | MP0002127_abnormal_cardiovascular_syste | 0.74670940 |
| 97 | MP0004484_altered_response_of | 0.74479992 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.72094285 |
| 99 | MP0000920_abnormal_myelination | 0.70834314 |
| 100 | MP0001970_abnormal_pain_threshold | 0.70808713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.22714590 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.94881856 |
| 3 | Nemaline bodies (HP:0003798) | 6.92051051 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.49376161 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.73589611 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.68471644 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.64769636 |
| 8 | Myopathic facies (HP:0002058) | 4.55429664 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.14863016 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 3.94994642 |
| 11 | Distal arthrogryposis (HP:0005684) | 3.88102208 |
| 12 | EMG: myopathic abnormalities (HP:0003458) | 3.79099686 |
| 13 | Asymmetric septal hypertrophy (HP:0001670) | 3.75107956 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.74073406 |
| 15 | Round ear (HP:0100830) | 3.69438948 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.64269706 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.64269706 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.64269706 |
| 19 | Myoglobinuria (HP:0002913) | 3.50317012 |
| 20 | Frequent falls (HP:0002359) | 3.48635848 |
| 21 | Rhabdomyolysis (HP:0003201) | 3.44992220 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.32874079 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 3.29365254 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.29107470 |
| 25 | Difficulty running (HP:0009046) | 3.18262432 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.11123938 |
| 27 | Increased connective tissue (HP:0009025) | 3.02200381 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.99987347 |
| 29 | Rimmed vacuoles (HP:0003805) | 2.92510116 |
| 30 | Muscle stiffness (HP:0003552) | 2.88928582 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.87783765 |
| 32 | Neck muscle weakness (HP:0000467) | 2.72867758 |
| 33 | Subaortic stenosis (HP:0001682) | 2.66768956 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.66768956 |
| 35 | Bulbar palsy (HP:0001283) | 2.65765827 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.48443976 |
| 37 | Fetal akinesia sequence (HP:0001989) | 2.46148063 |
| 38 | EMG: neuropathic changes (HP:0003445) | 2.43545657 |
| 39 | Mutism (HP:0002300) | 2.41710330 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.39249841 |
| 41 | Myotonia (HP:0002486) | 2.38935161 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.38763886 |
| 43 | Malignant hyperthermia (HP:0002047) | 2.38313371 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.38305028 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34495855 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34495855 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34495855 |
| 48 | Axonal loss (HP:0003447) | 2.32992830 |
| 49 | Loss of speech (HP:0002371) | 2.32075526 |
| 50 | Bundle branch block (HP:0011710) | 2.15538894 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.14822613 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.14058951 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.13660348 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.13603260 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.11021405 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11021405 |
| 57 | Disinhibition (HP:0000734) | 2.11005264 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09028772 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07428005 |
| 60 | Myositis (HP:0100614) | 2.02877409 |
| 61 | Nuclear cataract (HP:0100018) | 1.99842706 |
| 62 | J-shaped sella turcica (HP:0002680) | 1.99228592 |
| 63 | Generalized muscle weakness (HP:0003324) | 1.99164532 |
| 64 | Obstructive sleep apnea (HP:0002870) | 1.98923756 |
| 65 | Calcaneovalgus deformity (HP:0001848) | 1.98554376 |
| 66 | Sudden death (HP:0001699) | 1.97344750 |
| 67 | Abnormality of lateral ventricle (HP:0030047) | 1.96287781 |
| 68 | Stomatitis (HP:0010280) | 1.94999999 |
| 69 | Areflexia of lower limbs (HP:0002522) | 1.94874539 |
| 70 | Absent phalangeal crease (HP:0006109) | 1.93007623 |
| 71 | Slender build (HP:0001533) | 1.92688153 |
| 72 | Ventricular fibrillation (HP:0001663) | 1.92035298 |
| 73 | Spontaneous hematomas (HP:0007420) | 1.91649217 |
| 74 | Orchitis (HP:0100796) | 1.87956691 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83639486 |
| 76 | Scapular winging (HP:0003691) | 1.80535432 |
| 77 | Optic neuritis (HP:0100653) | 1.79868647 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 1.79868647 |
| 79 | Rapidly progressive (HP:0003678) | 1.79264146 |
| 80 | Stridor (HP:0010307) | 1.77543071 |
| 81 | Gowers sign (HP:0003391) | 1.77436502 |
| 82 | Waddling gait (HP:0002515) | 1.77013093 |
| 83 | Easy fatigability (HP:0003388) | 1.75463957 |
| 84 | Ankle clonus (HP:0011448) | 1.74856216 |
| 85 | Hematochezia (HP:0002573) | 1.74819828 |
| 86 | Neurofibrillary tangles (HP:0002185) | 1.73844714 |
| 87 | Nonprogressive disorder (HP:0003680) | 1.73199510 |
| 88 | Prolonged QT interval (HP:0001657) | 1.71907129 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 1.71641716 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.71192631 |
| 91 | Clumsiness (HP:0002312) | 1.70238209 |
| 92 | Hyperkalemia (HP:0002153) | 1.69136098 |
| 93 | Abnormality of the foot musculature (HP:0001436) | 1.67449278 |
| 94 | Deformed tarsal bones (HP:0008119) | 1.66873392 |
| 95 | Agitation (HP:0000713) | 1.66763775 |
| 96 | Muscular dystrophy (HP:0003560) | 1.66502381 |
| 97 | Recurrent abscess formation (HP:0002722) | 1.64630797 |
| 98 | Weak cry (HP:0001612) | 1.64077948 |
| 99 | Spinal rigidity (HP:0003306) | 1.63950130 |
| 100 | Foot dorsiflexor weakness (HP:0009027) | 1.63884639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.87840056 |
| 2 | PHKG1 | 3.46658879 |
| 3 | PHKG2 | 3.46658879 |
| 4 | TTN | 3.03868402 |
| 5 | PINK1 | 2.53038806 |
| 6 | MAP2K3 | 1.99237036 |
| 7 | MAP2K6 | 1.97341876 |
| 8 | SIK2 | 1.97293356 |
| 9 | TNK2 | 1.90014108 |
| 10 | MAP4K1 | 1.84226976 |
| 11 | TAOK2 | 1.80280942 |
| 12 | MAPK12 | 1.66547538 |
| 13 | BLK | 1.64972745 |
| 14 | TAOK1 | 1.50604045 |
| 15 | TBK1 | 1.46825117 |
| 16 | SIK1 | 1.44646230 |
| 17 | DAPK2 | 1.44361745 |
| 18 | MAP3K7 | 1.43991655 |
| 19 | MAP3K11 | 1.39832679 |
| 20 | ERN1 | 1.38463268 |
| 21 | TAOK3 | 1.35750790 |
| 22 | MARK1 | 1.32685310 |
| 23 | PRPF4B | 1.24288128 |
| 24 | RIPK1 | 1.22443636 |
| 25 | PIK3CG | 1.17551067 |
| 26 | MAP3K1 | 1.16909035 |
| 27 | MARK2 | 1.15677070 |
| 28 | EPHA3 | 1.13321383 |
| 29 | PRKD2 | 1.12296501 |
| 30 | RIPK4 | 1.11583914 |
| 31 | DYRK1B | 1.06449330 |
| 32 | MAP3K13 | 1.05829964 |
| 33 | TYK2 | 1.05451912 |
| 34 | TRIB3 | 1.05090345 |
| 35 | CDC42BPA | 1.01788646 |
| 36 | FRK | 0.99888036 |
| 37 | EPHB1 | 0.99331987 |
| 38 | MARK3 | 0.96195861 |
| 39 | FES | 0.96094213 |
| 40 | MAPK7 | 0.93520832 |
| 41 | CSF1R | 0.92346347 |
| 42 | MAP3K14 | 0.91881510 |
| 43 | ADRBK2 | 0.89248877 |
| 44 | MAP2K4 | 0.88677417 |
| 45 | DDR2 | 0.87120976 |
| 46 | KIT | 0.86680344 |
| 47 | IKBKB | 0.86007696 |
| 48 | TRPM7 | 0.84998501 |
| 49 | CSK | 0.84259168 |
| 50 | BCKDK | 0.82618380 |
| 51 | SYK | 0.79485444 |
| 52 | NME1 | 0.78777182 |
| 53 | PKN1 | 0.78063737 |
| 54 | MATK | 0.75216130 |
| 55 | IKBKE | 0.74955776 |
| 56 | MAP3K3 | 0.73081112 |
| 57 | TGFBR2 | 0.72862047 |
| 58 | MAPK13 | 0.72431627 |
| 59 | MAPK4 | 0.71953653 |
| 60 | MAP4K2 | 0.71624495 |
| 61 | HIPK2 | 0.70591078 |
| 62 | MAPKAPK3 | 0.70366014 |
| 63 | IRAK4 | 0.69535272 |
| 64 | GRK7 | 0.69301672 |
| 65 | RPS6KA2 | 0.67671484 |
| 66 | MUSK | 0.65304714 |
| 67 | PRKAA2 | 0.65074873 |
| 68 | BTK | 0.64937067 |
| 69 | JAK3 | 0.64479851 |
| 70 | MOS | 0.63841898 |
| 71 | ZAP70 | 0.61635746 |
| 72 | IRAK3 | 0.61616136 |
| 73 | EEF2K | 0.61077441 |
| 74 | RPS6KC1 | 0.60702287 |
| 75 | RPS6KL1 | 0.60702287 |
| 76 | NTRK3 | 0.59625285 |
| 77 | PRKAA1 | 0.58907974 |
| 78 | PDPK1 | 0.58836594 |
| 79 | CHUK | 0.58684138 |
| 80 | MAP3K6 | 0.58283178 |
| 81 | PDK1 | 0.57830004 |
| 82 | CAMK4 | 0.57628408 |
| 83 | NTRK2 | 0.56651680 |
| 84 | RPS6KA6 | 0.56628978 |
| 85 | FGR | 0.54821465 |
| 86 | PRKCH | 0.53858957 |
| 87 | HCK | 0.53680531 |
| 88 | JAK1 | 0.52562567 |
| 89 | LYN | 0.49914852 |
| 90 | CAMK1 | 0.48615262 |
| 91 | JAK2 | 0.47842193 |
| 92 | CAMKK1 | 0.47530647 |
| 93 | CAMK2G | 0.47358453 |
| 94 | LCK | 0.43901107 |
| 95 | SGK2 | 0.42533246 |
| 96 | MAPK11 | 0.42506129 |
| 97 | ICK | 0.42334634 |
| 98 | SGK3 | 0.41084241 |
| 99 | PRKCQ | 0.39661809 |
| 100 | TXK | 0.39380700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92204424 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87401024 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86819359 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.86421650 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80147675 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68754675 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.66804161 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.64057431 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.61011978 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49583200 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45733080 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.44650569 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.43674672 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40236213 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38908263 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37859708 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36420386 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35839662 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31283854 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29204029 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18330391 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17442445 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16388793 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15121232 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14605921 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.12493004 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12146390 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11541389 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.10335854 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10209855 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07659943 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07443788 |
| 33 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06423655 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03166961 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02391630 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01976423 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.01683271 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01146084 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 0.97817003 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96579511 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94571807 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94384302 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94031885 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93713871 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93636193 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90861499 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90428624 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89787555 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89505233 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89068080 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.87370313 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86650787 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85972273 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84924383 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84274830 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83097806 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83076342 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.82742853 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81893593 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81201957 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79649114 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78975130 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76743459 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76685806 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.75277328 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75252382 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74776214 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.73832097 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72461950 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.70599141 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70389186 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69790828 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69770258 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68605208 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.68564670 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67625369 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66814900 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65769306 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65506033 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64429229 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62820210 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62274798 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62003490 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60838342 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60553322 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60538216 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60048200 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57762485 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.57100305 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56887273 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.56717165 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54801271 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54051794 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.51796010 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50118764 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.50007866 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49477605 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48718455 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48666238 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48652344 |

